ABSTRACT

An adaptive seamless phase-II/III design is one of the most attractive adaptive

designs. A seamless adaptive design is a combination of traditional phase-II

and phase-III trials. In seamless design, there is usually a so-called learning

phase that serves the same purpose as a traditional phase-II trial, followed by

a confirmatory phase that serves the same objectives as a traditional phase-

III trial (Figure 7.1). Compared to traditional designs, a seamless design can

reduce sample-size and time-to-market for a positive drug candidate.